Marksans Pharma shares surged as much as 12.5 per cent to hit intraday high of Rs. 53.85 after the company announced that it has received US drug regulator's approval for a medicine used in treatment of sneezing, runny nose and other allergies.
Marksans, pharma surges, fda nod, new drug